+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Respiratory Disease Treatment Market - Global Forecast 2026-2032- Product Image
Bovine Respiratory Disease Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Bovine Respiratory Disease Treatment Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011091
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bovine Respiratory Disease Treatment Market is projected to reach USD 2.37 Billion in 2026. It is expected to continue growing at a CAGR of 8.05%, reaching USD 3.84 Billion by 2032.

Bovine respiratory disease (BRD) remains one of the most economically significant health challenges in cattle production, particularly in feedlot, dairy calf, and stocker operations. The condition is multifactorial, involving viral and bacterial pathogens, stress, commingling, transportation, nutrition, housing, and immune status. Veterinary authorities and academic extension programs consistently identify BRD as a leading cause of morbidity, treatment cost, production loss, and mortality in young cattle.

The bovine respiratory disease treatment landscape is shaped by the need to improve animal welfare, protect productivity, and support responsible antimicrobial use. Treatment decisions increasingly combine clinical examination, vaccination history, risk stratification, diagnostics, and post-treatment monitoring. As regulators, producers, veterinarians, and food companies intensify scrutiny of antimicrobial stewardship, the market is moving toward evidence-based BRD treatment protocols, earlier respiratory disease detection, targeted therapy, and integrated prevention strategies.

Transformative Shifts in BRD Treatment

The BRD treatment landscape is shifting from reactive, broad-based intervention toward preventive, data-informed herd health management. Vaccination programs, metaphylaxis decisions, preconditioning, biosecurity, nutrition, and low-stress handling are being aligned with therapeutic choices to reduce disease incidence and improve treatment outcomes. This shift is supported by veterinary guidance emphasizing accurate diagnosis, treatment records, responsible antimicrobial administration, and adherence to labeled withdrawal times.

Regulatory pressure is also changing product selection and clinical behavior. In the United States, medically important antimicrobials used in food-producing animals require veterinary oversight, and similar antimicrobial stewardship frameworks are advancing in Europe, Canada, and other major cattle-producing markets. At the same time, diagnostic tools, chute-side data capture, precision livestock monitoring, and herd management software are helping veterinarians distinguish high-risk animals, evaluate response to therapy, and reduce unnecessary antimicrobial exposure.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to affect bovine respiratory disease treatment by improving disease detection, risk scoring, and treatment decision support. Computer vision, acoustic monitoring, wearable sensors, feeding behavior analytics, and machine learning models can identify changes in activity, rumination, temperature, cough patterns, and feed intake that may precede visible clinical signs. These tools are most valuable when validated against veterinary diagnosis and integrated with farm-level records.

AI’s cumulative impact is expected to be strongest in antimicrobial stewardship, labor efficiency, and treatment outcome analysis. By flagging animals at higher risk, AI-enabled livestock health systems can support earlier examination and more targeted therapy, while treatment outcome analytics can help veterinarians refine BRD protocols over time. However, adoption depends on data quality, model transparency, interoperability, farm connectivity, cybersecurity, and clear veterinary accountability. AI should augment, not replace, licensed veterinary judgment in BRD treatment.

Key Regional Insights

In Asia-Pacific, growth in dairy and beef demand, expanding commercial farms, and government attention to food security are increasing the need for structured bovine respiratory disease prevention and treatment programs. China, India, Japan, South Korea, and Australia represent distinct demand profiles, ranging from large cattle populations and smallholder systems to highly regulated, technology-enabled production environments. Regional adoption is shaped by farm consolidation, vaccination access, veterinary service availability, climatic stress, long-distance animal movement, and rising expectations for safe animal protein.

North America remains a leading region for BRD treatment adoption due to large feedlot capacity, established veterinary infrastructure, formal veterinary-client-patient relationships, and extensive use of herd health protocols. Latin America, led by Brazil and Mexico, is influenced by export-oriented beef production and the need to maintain animal health standards across large, geographically diverse operations. Europe is shaped by strict antimicrobial stewardship policies, strong veterinary oversight, pharmacovigilance systems, and continued investment in vaccination, diagnostics, and welfare compliance. The Middle East shows rising demand where food security policies, high-value dairy operations, heat stress management, and import-dependent supply chains are increasing the need for reliable veterinary medicines. Africa is seeing gradual demand development as dairy modernization, cattle population expansion, transboundary disease control, and veterinary access initiatives increase the need for practical respiratory disease management.

Key Group Insights

ASEAN markets are increasingly focused on livestock modernization, dairy development, and veterinary capacity building, creating opportunities for BRD treatment protocols that are practical for mixed commercial and smallholder systems. GCC countries place emphasis on food security, high-value dairy operations, controlled-environment animal production, and dependable veterinary supply chains, which supports demand for preventive respiratory health programs and reliable treatment access.

The European Union strongly influences global BRD treatment practices through antimicrobial reduction policies, pharmacovigilance, prescription controls, and animal welfare standards. BRICS countries collectively represent large cattle inventories, fast-changing protein demand, and diverse veterinary access conditions, making scalable diagnostics, vaccination coverage, and affordable treatment options important. G7 markets typically lead in regulatory oversight, research adoption, antimicrobial stewardship, and digital herd health systems. NATO members overlap significantly with advanced veterinary medicine markets where animal health security, supply resilience, biosecurity, cross-border disease surveillance, and continuity of essential veterinary products are increasingly strategic priorities.

Key Country Insights

The United States is a core BRD treatment market because of its large feedlot sector, veterinary oversight requirements, established antimicrobial use regulations, and extensive research base. Canada has similar stewardship priorities, strong beef and dairy systems, and structured veterinary governance, while Mexico combines domestic beef and dairy demand with cross-border cattle trade dynamics that heighten the importance of disease prevention and treatment documentation. Brazil’s large beef industry creates substantial need for scalable respiratory disease management across diverse production systems, and Australia’s extensive cattle systems place emphasis on preventive management, animal movement controls, biosecurity, welfare assurance, and export compliance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are shaped by strong veterinary governance, antimicrobial reduction goals, dairy-beef integration, and high expectations for traceability and responsible medicine use. Russia maintains demand linked to domestic livestock development, regional supply considerations, climatic stressors, and efforts to strengthen veterinary capacity. China and India are major long-term opportunities due to herd size, dairy modernization, food security policy, and rising demand for animal protein, though farm structure, diagnostic access, and veterinary service coverage vary widely. Japan and South Korea emphasize high standards, traceability, biosecurity, and regulated veterinary care, supporting premium treatment protocols and technology-enabled monitoring.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated BRD programs that combine vaccination, nutrition, biosecurity, transportation management, diagnostics, low-stress handling, and evidence-based treatment protocols. Organizations that support veterinarians with decision tools, continuing education, pharmacovigilance data, residue prevention guidance, and clear labeling support will be better positioned as antimicrobial stewardship expectations increase.

Suppliers should also invest in rapid diagnostics, data interoperability, AI-assisted monitoring, and treatment outcome analytics that support earlier intervention without encouraging unnecessary medication. Regional strategies should account for local regulations, cattle production models, veterinary access, climate conditions, animal movement patterns, and cold-chain capabilities. Partnerships with veterinarians, universities, producer groups, public agencies, and regulators can strengthen trust and accelerate adoption of responsible bovine respiratory disease treatment solutions.

Research Methodology

This executive summary is developed using a secondary research framework grounded in verified public sources, including veterinary regulatory agencies, animal health authorities, peer-reviewed literature, university extension guidance, industry standards, and international organizations such as WOAH, FAO, WHO, FDA, USDA, EMA, and national agriculture departments.

The analysis triangulates clinical practice trends, antimicrobial stewardship policies, livestock production indicators, regional cattle industry structures, veterinary access conditions, disease management guidance, and technology adoption signals. Insights are interpreted through a market intelligence lens to identify drivers, constraints, regional differences, and strategic implications for bovine respiratory disease treatment stakeholders, while avoiding market sizing, market share, and forecasting assumptions.

Conclusion

Bovine respiratory disease treatment is evolving from product-centered therapy toward integrated, evidence-based respiratory health management. The strongest opportunities are emerging where veterinary oversight, diagnostics, vaccination, data analytics, and responsible antimicrobial use are combined into practical protocols that improve outcomes, reduce preventable losses, and support animal welfare.

As regulatory scrutiny and producer expectations rise, stakeholders that demonstrate clinical value, stewardship alignment, supply reliability, traceability, and digital readiness will strengthen competitive positioning. The future of BRD treatment will be defined by earlier detection, targeted intervention, and collaborative herd health systems that support sustainable cattle production and responsible access to effective veterinary care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bovine Respiratory Disease Treatment Market, by Product Type
7.1. Introduction
7.2. Antibiotics
7.2.1. Beta Lactams
7.2.2. Fluoroquinolones
7.2.3. Macrolides
7.2.3.1. Tilmicosin
7.2.3.2. Tulathromycin
7.2.3.3. Tylosin
7.2.4. Tetracyclines
7.3. Vaccines
7.3.1. Inactivated
7.3.2. Live Attenuated
8. Bovine Respiratory Disease Treatment Market, by Route Of Administration
8.1. Introduction
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Intravenous
8.2.3. Subcutaneous
8.3. Intranasal
8.4. Oral
9. Bovine Respiratory Disease Treatment Market, by Treatment Type
9.1. Introduction
9.2. Therapeutic Treatment
9.3. Preventive Treatment
9.4. Metaphylactic Treatment
10. Bovine Respiratory Disease Treatment Market, by Animal Type
10.1. Introduction
10.2. Adult Cattle
10.2.1. Beef Cattle
10.2.2. Dairy Cows
10.3. Calves
10.3.1. Beef Calves
10.3.2. Dairy Calves
10.4. Heifers
11. Bovine Respiratory Disease Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Feed Mills
11.2.1. Commercial Mills
11.2.2. Onfarm Mills
11.3. Online Pharmacies
11.3.1. Animal Health Platforms
11.3.2. General ERetail
12. Bovine Respiratory Disease Treatment Market, by End-User
12.1. Introduction
12.2. Veterinary Hospitals & Clinics
12.3. Livestock Farms
12.4. Feedlots
12.5. Animal Husbandry Organizations
12.6. Government Veterinary Programs
13. Bovine Respiratory Disease Treatment Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Bovine Respiratory Disease Treatment Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Bovine Respiratory Disease Treatment Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aratana Therapeutics, Inc.
17.2. Ashish Life Science Pvt. Ltd.
17.3. Bimeda Inc.
17.4. Boehringer Ingelheim International GmbH
17.5. Ceva Santé Animale S.A.
17.6. Dechra Pharmaceuticals PLC
17.7. Elanco Animal Health Incorporated
17.8. Hester Biosciences Ltd.
17.9. Huvepharma AD
17.10. IDEXX Laboratories, Inc.
17.11. India Immunologicals Ltd.
17.12. Inovio Pharmaceuticals, Inc.
17.13. Intas Pharmaceuticals Ltd.
17.14. Kyoritsu Seiyaku Corporation
17.15. Med-Pharmex Ltd.
17.16. Meiji Holdings Co., Ltd.
17.17. Merck & Co., Inc.
17.18. Neogen Corporation
17.19. Novartis Animal Health
17.20. Ourofino Saúde Animal S.A.
17.21. Phibro Animal Health Corporation
17.22. Plumbline Life Sciences
17.23. Vetoquinol S.A.
17.24. Vetsfarma Ltd.
17.25. Virbac S.A.
17.26. Zoetis Inc.
17.27. Zydus Animal Health and Investments Limited
List of Figures
FIGURE 1. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TILMICOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TILMICOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TILMICOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL TULATHROMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL TULATHROMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL TULATHROMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TYLOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TYLOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TYLOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INACTIVATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INACTIVATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INACTIVATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LIVE ATTENUATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LIVE ATTENUATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LIVE ATTENUATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INTRANASAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INTRANASAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INTRANASAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL THERAPEUTIC TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL THERAPEUTIC TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL THERAPEUTIC TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PREVENTIVE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PREVENTIVE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PREVENTIVE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL METAPHYLACTIC TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL METAPHYLACTIC TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL METAPHYLACTIC TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ADULT CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ADULT CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ADULT CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DAIRY COWS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DAIRY COWS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DAIRY COWS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BEEF CALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BEEF CALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BEEF CALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DAIRY CALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DAIRY CALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DAIRY CALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HEIFERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HEIFERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HEIFERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL FEED MILLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL FEED MILLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL FEED MILLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL COMMERCIAL MILLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL COMMERCIAL MILLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL COMMERCIAL MILLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ONFARM MILLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ONFARM MILLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ONFARM MILLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ANIMAL HEALTH PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ANIMAL HEALTH PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ANIMAL HEALTH PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GENERAL ERETAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GENERAL ERETAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GENERAL ERETAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL FEEDLOTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL FEEDLOTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL FEEDLOTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ANIMAL HUSBANDRY ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ANIMAL HUSBANDRY ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ANIMAL HUSBANDRY ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL GOVERNMENT VETERINARY PROGRAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL GOVERNMENT VETERINARY PROGRAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL GOVERNMENT VETERINARY PROGRAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 169. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 172. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 173. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 174. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 175. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 176. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 177. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 179. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 180. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 182. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 183. EUROPE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 199. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 203. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 204. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 205. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 206. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 207. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 208. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 209. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 210. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 211. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 212. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 213. AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 217. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 218. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 219. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 220. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 221. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 222. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 223. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 224. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 225. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 226. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 228. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 229. ASEAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 230. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 233. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 234. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 235. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 236. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 237. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 238. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 239. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 240. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 241. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 242. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 243. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 244. GCC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 260. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 263. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 264. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 265. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 266. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 267. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 268. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 269. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 270. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 271. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 273. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 274. BRICS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 275. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 278. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 279. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 280. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 281. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 282. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 283. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 284. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 285. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 286. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 287. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 288. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 289. G7 BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 290. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 293. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 294. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 295. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 296. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 297. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 298. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 299. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 300. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 301. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 303. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 304. NATO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 305. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 315. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2017-2032 (USD MILLION)
TABLE 316. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2017-2032 (USD MILLION)
TABLE 317. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 318. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2017-2032 (USD MILLION)
TABLE 319. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2017-2032 (USD MILLION)
TABLE 320. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 321. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 322. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 323. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 324. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 325. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 326. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 327. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 328. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLIO

Companies Mentioned

  • Aratana Therapeutics, Inc.
  • Ashish Life Science Pvt. Ltd.
  • Bimeda Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Ltd.
  • Huvepharma AD
  • IDEXX Laboratories, Inc.
  • India Immunologicals Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Med-Pharmex Ltd.
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Novartis Animal Health
  • Ourofino Saúde Animal S.A.
  • Phibro Animal Health Corporation
  • Plumbline Life Sciences
  • Vetoquinol S.A.
  • Vetsfarma Ltd.
  • Virbac S.A.
  • Zoetis Inc.
  • Zydus Animal Health and Investments Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.84 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Bovine Respiratory Disease Treatment - Global Strategic Business Report - Product Image

Bovine Respiratory Disease Treatment - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Bovine Respiratory Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Bovine Respiratory Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Ceftiofur Market - Global Forecast 2026-2032 - Product Image

Ceftiofur Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Veterinary Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Bovine Treatment Systems - Global Strategic Business Report - Product Image

Bovine Treatment Systems - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From

About the Market

The Bovine Respiratory Diseases Drug market is a segment of the Animal Pharmaceuticals industry that focuses on the development and sale of drugs used to treat respiratory diseases in cattle. These drugs are used to treat a variety of conditions, including pneumonia, bronchitis, and other respiratory infections. The drugs are typically administered orally or through injection, and may be used in combination with other treatments. The market is highly competitive, with a number of companies offering a variety of products. The Bovine Respiratory Diseases Drug market is driven by the increasing prevalence of respiratory diseases in cattle, as well as the need for effective treatments. Additionally, the development of new drugs and technologies has enabled the market to expand. Some of the major companies in the Bovine Respiratory Diseases Drug market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.